Oral MCP enhances anti-cancer, anti-metastatic effects of radiotherapy in prostate cancer treatment

Scientists at Tel Aviv Medical Center, Israel, have found that oral modified citrus pectin enhances the anti-cancer and anti-metastatic effects of radiotherapy in the treatment of androgen-independent aggressive prostate cancer cells. Results were presented at the American Association for Cancer Research Annual Meeting 2015.

News Medical